您的购物车当前为空
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization.
别名 TG-0054 hydrobromide
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 990 | 6-8周 | |
| 10 mg | ¥ 1,580 | 6-8周 | |
| 25 mg | ¥ 2,850 | 6-8周 | |
| 50 mg | ¥ 4,640 | 6-8周 | |
| 100 mg | ¥ 7,170 | 6-8周 | |
| 200 mg | ¥ 11,800 | 6-8周 | |
| 500 mg | ¥ 23,800 | 6-8周 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
该分子属于定制产品。TargetMol拥有优秀的合成团队,经验和能力,可以为您提供高性价比的产品。 但由于客观因素,研发中会存在小概率合成不成功的情况,还请理解。 如您有任何问题,欢迎咨询,我们将竭诚为您服务。
| 产品描述 | Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization. |
| 体外活性 | Burixafor hydrobromide mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction [2]. |
| 别名 | TG-0054 hydrobromide |
| 分子量 | 647.644 |
| 分子式 | C27H52BrN8O3P |
| CAS No. | 1191450-19-7 |
| Smiles | Br.Nc1cc(nc(NCC2CCC(CNCCCNC3CCCCC3)CC2)n1)N1CCN(CCP(O)(O)=O)CC1 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | ||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 50 mg/mL (77.2 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
H2O
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | |||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多